Lgbtq
Gender-affirming hormone therapy tied to changes in BP
Gender-affirming hormone therapy may cause a decrease in mean systolic BP in transgender women and an increase in mean systolic BP in transgender men, researchers reported.
Timing of HT during puberty influences bone development in transgender adolescents
Transgender adolescents treated with gender-affirming hormone therapy early in puberty experience bone development more similar to that of their experienced gender compared with their gender assigned at birth, according to study data.
Telemedicine provides expanded access to gender-affirming care for youths
Telemedicine visits for gender-affirming care in minors rapidly increased during the COVID-19 pandemic and may be able to expand access to care in the future, according to data from two studies published in Transgender Health.
Arkansas outlaws gender-affirming treatment for minors, prompting outcry from providers
Arkansas on Tuesday became the first state to outlaw any gender-affirming medical treatments for minors who may be transgender, overriding a veto from the governor and prompting outcry from providers and advocates.
Think beyond the CV: Ann Danoff, MD, shares advice for future endocrinologists
Ann Danoff, MD, had already established herself as a professional modern dancer performing in New York City when she picked up a friend’s copy of Cells and Organelles and saw the first parallels between movement and endocrinology.
Supporting transgender care: A conversation with Frances J. Hayes, MD, MBBCh
Author of the Endocrine Society’s Clinical Practice Guideline on testosterone therapy for hypogonadism, Frances J. Hayes, MD, MBBCh, is nationally recognized for her expertise in testosterone deficiency.
More data needed as LGBTQ+ populations face disparities in CV health
CVD mortality has steadily decreased in the U.S. for some populations, but mounting data indicate LGBTQ+ adults have worse CV health compared with their straight, cisgender counterparts.
Gender-affirming HT influences HDL cholesterol levels in adolescents
Gender-affirming hormone therapy causes changes in HDL cholesterol levels for transgender adolescents, and obesity can modify these associations, according to a research letter published in JAMA Pediatrics.
Erythrocytosis present in 11% of transgender men receiving testosterone therapy
Eleven percent of transgender men using testosterone develop erythrocytosis, increasing their risks for blood clots, myocardial infarction and stroke, according to a study published in The Journal of Clinical Endocrinology & Metabolism.
Testosterone therapy linked to BMI gains in adolescent transgender males
A cohort of transgender male adolescents on testosterone therapy had a significant increase in BMI during a mean follow-up of nearly 1 year, a trend not seen in a cohort of BMI-matched cisgender females, according to study data.